InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,303.27
(
0.12%
)
US TECH 100
18,066.00
(
-0.07%
)
Dow Jones
40,003.59
(
0.34%
)
Brent Oil
83.76
(
0.00%
)
Bitcoin
66,863.74
(
-0.32%
)
Post# of 30046
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

GetSeriousOK

Send PM Follow Ignore
Followers 38
Posts 6909
Boards Moderated 1
Alias Born 09/06/2014

GetSeriousOK

Re: dcspka post# 25146

Sunday, 09/14/2014 8:53:49 PM

Sunday, September 14, 2014 8:53:49 PM

Post# of 30046
It is highly unlikely that anyone will develop CIT anywhere.

Radient hired Dr. Chang to work on CIT in November 2010 and within four weeks Radient abandoned CIT and licensed Dr. Chang's newer work at the Univ of Florida. Doesn't that make it VERY clear that the inventor of CIT (Chang) and the owner of CIT (Radient) thought it was a waste of resources to develop CIT when Dr. Chang's newer work was available?

If Provista wanted an immunotherapy product in their pipeline, they would license Dr. Chang's work at the Univ of Florida instead of developing CIT, IMO. Anyone would after reading Radient's 2010 and 2011 10K's.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up